Displaying drugs 2151 - 2175 of 2779 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Lacidipine | 455.551 C26H33NO6 |  | A lipophilic dihydropyridine calcium channel blocker with a slow onset of action used to treat hypertension. | Dihydropyridine Derivatives |
| Zinc gluconate | 455.67 C12H22O14Zn |  | An ingredient found in a variety of supplements and vitamins. | Zinc Compounds |
| Clevidipine | 456.316 C21H23Cl2NO6 |  | A dihydropyridine L-type calcium channel blocker used to lower blood pressure when oral antihypertensive therapy is not feasible or not desirable. | Dihydropyridine Derivatives |
| Flavin mononucleotide | 456.3438 C17H21N4O9P |  | A form of vitamin B2 used to restore riboflavin in anemia, migraine, alcoholism, and hyperhomocysteinemia. | Ribonucleotides / Vitamin B Complex |
| Delavirdine | 456.561 C22H28N6O3S |  | A non-nucleoside reverse transcriptase inhibitor used to treat HIV infection. | Non-Nucleoside Reverse Transcriptase Inhibitors |
| Dequalinium | 456.6654 C30H40N4 |  | A quaternary ammonium cation antimicrobial agent used to treat common infections of the mouth and throat, as well as vaginal candidiasis. | Anti-Infective Agents, Local / Quinoline Derivatives |
| Betulinic Acid | 456.711 C30H48O3 |  | Betulinic Acid has been used in trials studying the treatment of Dysplastic Nevus Syndrome. | Agents that produce hypertension |
| Testosterone undecanoate | 456.711 C30H48O3 |  | An androgen indicated for testosterone replacement therapy in adult males with primary hypogonadism and hypogonadotropic hypogonadism. | Androgens |
| Minocycline | 457.4764 C23H27N3O7 |  | A tetracycline analog used to treat a wide variety of infections in the body. | Antiinfectives and Antiseptics for Local Oral Treatment / Antiinfectives for Treatment of Acne |
| Etrasimod | 457.493 C26H26F3NO3 |  | An S1P receptors modulator used to treat moderate to severely active ulcerative colitis in adults | Acids, Acyclic / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Fatty Acids / Fatty Acids, Volatile / Heterocyclic Compounds, Fused-Ring / Lipids |
| Selumetinib | 457.68 C17H15BrClFN4O3 |  | A MEK 1/2 inhibitor used in pediatric patients to treat neurofibromatosis type 1 (NF1) accompanied by symptomatic, inoperable plexiform neurofibromas (PN). | Mitogen-activated protein kinase (MEK) inhibitors |
| Lanthanum carbonate | 457.835 C3La2O9 |  | A phosphate binder indicated for the reduction of serum phosphate in patients with end stage renal disease. | Drugs for Treatment of Hyperkalemia and Hyperphosphatemia |
| Raltitrexed | 458.488 C21H22N4O6S |  | A folate analog thymidylate synthase inhibitor used in the treatment of advanced colorectal cancer. | Folic Acid Analogues |
| Astemizole | 458.5703 C28H31FN4O |  | A second generation antihistamine used to treat allergy symptoms. | Anti-Allergic Agents / Benzimidazoles / Histamine H1 Antagonists, Non-Sedating |
| Prednisolone tebutate | 458.587 C27H38O6 |  | Not Annotated | Fused-Ring Compounds / Pregnadienes / Pregnadienetriols / Pregnanes / Steroids |
| Elacestrant | 458.646 C30H38N2O2 |  | An estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. | Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP2A6 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Endocrine Therapy / Estrogen Receptor Antagonists / Estrogens, Non-Steroidal / Naphthalenes / OATP2B1/SLCO2B1 substrates / P-glycoprotein inhibitors / Selective Estrogen Receptor Degraders |
| Levomefolic acid | 459.4558 C20H25N7O6 |  | A folate supplement used to prevent neural tube defects in pregnancy or folate deficiency. | Amino Acids / Amino Acids, Acidic / Amino Acids, Dicarboxylic / Amino Acids, Peptides, and Proteins / Coenzymes / Enzymes and Coenzymes / Folate Analog / Folic Acid and Derivatives / Heterocyclic Compounds, Fused-Ring / Pteridines / Pterins / Vitamin B Complex / Vitamins |
| Apixaban | 459.4971 C25H25N5O4 |  | An anticoagulant used for the prophylaxis of stroke and systemic embolism in nonvalvular atrial fibrillation, and deep vein thrombosis(DVT) leading to pulmonary embolism(PE), including in patients after a hip or knee replacement surgery. | Direct factor Xa inhibitors / Factor Xa Inhibitors |
| Cerivastatin | 459.5503 C26H34FNO5 |  | A statin (or HMG CoA reductase inhibitor) used with dietary changes to decrease lipid levels and reduce the risk of cardiovascular events. | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| Trifarotene | 459.586 C29H33NO4 |  | A topical retinoid indicated for the treatment of acne vulgaris. | Retinoids for Topical Use in Acne |
| Oxytetracycline | 460.434 C22H24N2O9 |  | A tetracycline antibiotic used to treat a wide variety of susceptible bacterial infections. | Anti-Bacterial Agents / Antiinfectives and Antiseptics for Local Oral Treatment |
| Apremilast | 460.5 C22H24N2O7S |  | A non-steroidal medication used for the treatment of inflammatory conditions such as psoriasis and psoriatic arthritis. | Selective Immunosuppressants |
| Ponesimod | 460.97 C23H25ClN2O4S |  | A sphingosine 1-phosphate receptor modulator indicated to treat relapsing multiple sclerosis. | Selective Immunosuppressants |
| Azlocillin | 461.492 C20H23N5O6S |  | For the treatment of infections caused by Pseudomonas aeruginosa, Escherichia coli, and Haemophilus influenzae. | Penicillins With Extended Spectrum |
| Pimozide | 461.5462 C28H29F2N3O |  | An antipsychotic used to manage debilitating motor and phonic tics in patients with Tourette's Disorder. | Diphenylbutylpiperidine Derivatives |
Displaying drugs 2151 - 2175 of 2779 in total